HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD
HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (China) holds 19 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 19 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hubei-biocause-heilen-pharmaceutical-co-ltd
Overview
HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 17 active FDA Type II Drug Master Files, covering ABIRATERONE ACETATE; ATROPINE SULFATE; CLADRIBINE DRUG SUBSTANCE; DEXIBUPROFEN DRUG SUBSTANCE; DEXMEDETOMIDINE DRUG SUBSTANCE; DEXMEDETOMIDINE HYDROCHLORIDE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD holds 19 active (19 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- AZACITIDINE DRUG SUBSTANCEActive2026-06-10
- IBUPROFEN LYSINATE DRUG SUBSTANCEActive2026-04-21
- INDOCYANINE GREEN USPActive2025-11-22
- DEXMEDETOMIDINE HYDROCHLORIDE USPActive2025-09-29
- IBUPROFEN ARGININE DRUG SUBSTANCEActive2025-05-14
- CLADRIBINE DRUG SUBSTANCEActive2024-05-10
- DEXMEDETOMIDINE DRUG SUBSTANCEActive2021-08-23
- DEXIBUPROFEN DRUG SUBSTANCEActive2020-11-09
- FLUDARABINE PHOSPHATE DRUG SUBSTANCEActive2020-04-29
- HOMATROPINE HYDROBROMIDEActive2019-09-29
- ATROPINE SULFATEActive2014-12-25
- HYOSCYAMINE SULFATEActive2014-09-02
- HOMATROPINE METHYLBROMIDEActive2014-07-28
- ABIRATERONE ACETATEActive2013-12-24
- Fludarabine Phosphate Drug SubstanceActive2007-11-12
- MILRINONEActive2006-08-31
- FLUMAZENILActive2006-08-31
- GRANISETRON HYDROCHLORIDE, NON-STERILE BULK DRUG SUBSTANCEActive2005-12-15
- IBUPROFEN USPActive2002-01-25
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.